ATE472321T1 - Pantethin enthaltendes teilchenförmiges produkt - Google Patents

Pantethin enthaltendes teilchenförmiges produkt

Info

Publication number: ATE472321T1
Authority: AT; Austria
Prior art keywords: pantethine; product containing; particle product; microcrystalline cellulose; silicic acid
Prior art date: 2002-09-30

Application number

AT03798538T

Other languages

English (en)

Inventor

M Kidokoro

Y Tsutsumi

Mitsumasa Nada

Original Assignee

Daiichi Seiyaku Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-09-30

Filing date

2003-09-29

Publication date

2010-07-15

2003-09-29 Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co

2010-07-15 Application granted granted Critical

2010-07-15 Publication of ATE472321T1 publication Critical patent/ATE472321T1/de

Links

DJWYOLJPSHDSAL-UHFFFAOYSA-N Pantethine Natural products OCC(C)(C)C(O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)C(O)C(C)(C)CO DJWYOLJPSHDSAL-UHFFFAOYSA-N 0.000 title abstract 3
DJWYOLJPSHDSAL-ROUUACIJSA-N pantethine Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)CO DJWYOLJPSHDSAL-ROUUACIJSA-N 0.000 title abstract 3
229960000903 pantethine Drugs 0.000 title abstract 3
235000008975 pantethine Nutrition 0.000 title abstract 3
239000011581 pantethine Substances 0.000 title abstract 3
239000002245 particle Substances 0.000 title abstract 2
229920000168 Microcrystalline cellulose Polymers 0.000 abstract 2
235000019813 microcrystalline cellulose Nutrition 0.000 abstract 2
239000008108 microcrystalline cellulose Substances 0.000 abstract 2
229940016286 microcrystalline cellulose Drugs 0.000 abstract 2
RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 abstract 2
235000012239 silicon dioxide Nutrition 0.000 abstract 2
230000000903 blocking effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Inorganic Chemistry (AREA)
Endocrinology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Cosmetics (AREA)
Detergent Compositions (AREA)

AT03798538T 2002-09-30 2003-09-29 Pantethin enthaltendes teilchenförmiges produkt ATE472321T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2002286286		2002-09-30
PCT/JP2003/012408 WO2004028523A1 (ja)	2002-09-30	2003-09-29	パンテチン含有粒状物

Publications (1)

Publication Number	Publication Date
ATE472321T1 true ATE472321T1 (de)	2010-07-15

Family

ID=32040603

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT03798538T ATE472321T1 (de)	2002-09-30	2003-09-29	Pantethin enthaltendes teilchenförmiges produkt

Country Status (10)

Country	Link
US (1)	US7709028B2 (de)
EP (1)	EP1547584B1 (de)
JP (1)	JP4496078B2 (de)
CN (1)	CN100362987C (de)
AT (1)	ATE472321T1 (de)
AU (1)	AU2003266676A1 (de)
CA (1)	CA2501021C (de)
DE (1)	DE60333207D1 (de)
ES (1)	ES2345713T3 (de)
WO (1)	WO2004028523A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPWO2011030727A1 (ja)	2009-09-11	2013-02-07	第一ファインケミカル株式会社	パンテチンリン酸エステルを含む外用剤
FR2958166B1 (fr) *	2010-04-06	2012-07-13	Assist Publ Hopitaux De Paris	Compositions pharmaceutiques fortement dosees en biotine
FR2993780B1 (fr)	2012-07-26	2015-02-13	Assist Publ Hopitaux De Paris	Methode de traitement de la sclerose en plaque
WO2014177286A1 (en)	2013-04-29	2014-11-06	Assistance Publique - Hopitaux De Paris	Biotin for use in treating x-linked adrenoleukodystrophy

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS532931B2 (de) *	1973-12-05	1978-02-01
JPS54122737A (en) *	1978-03-13	1979-09-22	Dai Ichi Seiyaku Co Ltd	Remedy for pericementosis
JPS54126737A (en) *	1978-03-17	1979-10-02	Dai Ichi Seiyaku Co Ltd	Antithrombotic agent
JPS5538344A (en)	1978-09-12	1980-03-17	Dai Ichi Seiyaku Co Ltd	Manufacturing of pantethine powder
JPS5936606A (ja) *	1982-08-26	1984-02-28	Sogo Yatsukou Kk	美白化粧料
JPS5949840A (ja) *	1982-09-14	1984-03-22	Taiyo Yakuhin Kogyo Kk	顆粒、細粒の固着防止方法
JPS6479119A (en) *	1987-09-22	1989-03-24	Daiichi Seiyaku Co	Drug of blended two components
US4910023A (en)	1988-06-09	1990-03-20	Warner-Lambert Company	Drug in combination with flavor masking agent and method for making same
JPH07233070A (ja)	1994-02-23	1995-09-05	Taisho Pharmaceut Co Ltd	疲労改善剤
JPH09143088A (ja) *	1995-09-21	1997-06-03	Taisho Pharmaceut Co Ltd	滋養強壮保健剤
RU2189227C2 (ru) *	1996-07-12	2002-09-20	Дайити Фармасьютикал Ко., Лтд.	Быстро распадающиеся прессованные в формах материалы и способ их получения
JP2001187734A (ja) *	1999-12-28	2001-07-10	Taisho Pharmaceut Co Ltd	２型ｔヘルパー細胞分化抑制剤

2003
- 2003-09-29 CA CA2501021A patent/CA2501021C/en not_active Expired - Lifetime
- 2003-09-29 DE DE60333207T patent/DE60333207D1/de not_active Expired - Lifetime
- 2003-09-29 CN CNB038232332A patent/CN100362987C/zh not_active Expired - Lifetime
- 2003-09-29 AU AU2003266676A patent/AU2003266676A1/en not_active Abandoned
- 2003-09-29 US US10/529,207 patent/US7709028B2/en not_active Expired - Lifetime
- 2003-09-29 AT AT03798538T patent/ATE472321T1/de not_active IP Right Cessation
- 2003-09-29 WO PCT/JP2003/012408 patent/WO2004028523A1/ja not_active Ceased
- 2003-09-29 EP EP03798538A patent/EP1547584B1/de not_active Expired - Lifetime
- 2003-09-29 JP JP2004539566A patent/JP4496078B2/ja not_active Expired - Lifetime
- 2003-09-29 ES ES03798538T patent/ES2345713T3/es not_active Expired - Lifetime

Also Published As

Publication number	Publication date
EP1547584A4 (de)	2005-12-14
AU2003266676A1 (en)	2004-04-19
JPWO2004028523A1 (ja)	2006-01-19
CA2501021C (en)	2011-02-22
CN100362987C (zh)	2008-01-23
ES2345713T3 (es)	2010-09-30
EP1547584A1 (de)	2005-06-29
WO2004028523A1 (ja)	2004-04-08
CN1697653A (zh)	2005-11-16
US20060068016A1 (en)	2006-03-30
DE60333207D1 (de)	2010-08-12
EP1547584B1 (de)	2010-06-30
JP4496078B2 (ja)	2010-07-07
US7709028B2 (en)	2010-05-04
CA2501021A1 (en)	2004-04-08

Legal Events

Date	Code	Title	Description
2010-12-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
CY1114668T1 (el)	2016-10-05	Κοκκια περιεχοντα λανσοπραzολη σε μεγαλη ποσοτητα
DK1353548T3 (da)	2006-02-20	Formalet kornströelse til dyr
EA199900318A1 (ru)	1999-12-29	Способ производства гранул цеолита х с низким содержанием двуокиси кремния с низким содержанием инертного связующего
ATE419835T1 (de)	2009-01-15	Nystatin-nanopartikelzusammensetzungen
WO2005013937A3 (en)	2005-06-16	Novel compositions of sildenafil free base
ATE321838T1 (de)	2006-04-15	Zusammensetzungen mit niedriger dichte und partikeln der diese enthalten
DK0891417T3 (da)	2002-07-01	Sammensætninger, der indeholder natriumpercarbonat
MXPA04003856A (es)	2004-07-08	Formulacion granular de montelukast.
MEP53708A (en)	2011-05-10	3-z-[1-(4-(n-((4-methyl-piperazin-1-yl)-methylcarbonyl) -n-methyl -amino) -anilino)-1- phenyl-methylene] -6-methoxycarbonyl -2-indolinone -monoethanesulphonate and the use thereof as a pharmaceutical composition
IS4326A (is)	1996-03-04	Ný forðakyrni og lyfjablanda sem inniheldur þau
EA200801468A1 (ru)	2009-04-28	Препараты ганаксолона и способы их получения и применения
NO332857B1 (no)	2013-01-21	Inhalasjonskapsel samt anvendelse av slike
ATE308343T1 (de)	2005-11-15	Trägerhilfstoff
DK2162016T3 (da)	2012-07-23	Tyggegummigranuler til komprimattyggegummi
BR0213608A (pt)	2004-09-14	Composição oral
WO2007053197A3 (en)	2007-11-29	Nanoparticulate acetaminophen formulations
NO20055943L (no)	2006-01-25	Bicalutamidformer, sammensetninger og fremgangsmater derav
NO20071556L (no)	2007-03-26	Imazalilsammensetninger omfattende alkoksylerte aminer
BR0315808A (pt)	2005-09-20	Composições biocìdicas aquosa e sólida contendo bromo ativo e processo de produção destas
TR200401793T4 (tr)	2004-08-23	Perindopril tuzu ve bunu içeren farmasötik bileşimler.
DE60333207D1 (de)	2010-08-12	Pantethin enthaltendes teilchenförmiges produkt
ATE232728T1 (de)	2003-03-15	Feuchtigkeitsstabile cefuroxim axetil enthaltende pharmazeutische zusammenstellungen
ATE357217T1 (de)	2007-04-15	Pharmazeutische zusammensetzung enthaltend lamotrigine-partikel mit definierter morphologie
DE60236025D1 (de)	2010-05-27	Pharmazeutische zusammensetzung enthaltend l-arginin
TW200518785A (en)	2005-06-16	Pharmaceutical formulation